Uğur Şahin’s net worth over time
Only dates with a published estimate are shown. Nothing is filled in between. Tap or hover a bar to see the source.
See the numbers as a table
| Date | Estimate | Source |
| 2021 | $4 billion | Forbes World's Billionaires List 2021 |
| 2022 | $5.3 billion | Forbes World's Billionaires List 2022 |
| 2023 | $5 billion | Forbes World's Billionaires List 2023 |
| 2024 | $3.7 billion | Forbes World's Billionaires List 2024 |
| 2025 | $4.3 billion | Forbes World's Billionaires List 2025 |
| 2026 | $4.7 billion | Forbes World's Billionaires List 2026 |
| Oct 2026 | $3.9 billion | Forbes Real-Time Billionaires · Forbes real-time estimate |
Where the money comes from
These are the main sources of wealth named in the reporting we cite. No published source breaks the total into exact amounts, so we do not show percentages.
Uğur Şahin’s fortune in real-life terms
Based on the Forbes Real-Time Billionaires estimate above. Median full-time U.S. pay is $65,416 a year ($1,258 a week, BLS, Q2 2026), before taxes. Typical (median) U.S. family net worth is $216,100 (Federal Reserve, 2025 Survey of Consumer Finances).
How do you compare to Uğur Şahin? New
Type your yearly income and see how you stack up. It runs in your browser: nothing you type is saved or sent anywhere.
Uğur Şahin has an estimated net worth of $3.9 billion, according to Forbes Real-Time Billionaires, Uğur Şahin profile (figures as of October 20, 2026). That is down from a peak of $5.3 billion.
Uğur Şahin is a German medical researcher, entrepreneur, and businessman best known for cofounding and leading BioNTech. He trained as a doctor and worked as a researcher and professor, with a long focus on cancer research and immunology. Before BioNTech became widely known, he built his career in academic medicine and oncology. He also helped found HI-TRON in 2018 and is linked to more than 500 patent applications and patents.
His wealth comes from biotechnology. In 2001, Şahin and Özlem Türeci cofounded Ganymed Pharmaceuticals, a drug company later acquired by Astellas Pharma in 2016 for $460 million. In 2008, the pair cofounded BioNTech with backing from Thomas and Andreas Struengmann. BioNTech went public on the Nasdaq in October 2019. Şahin owns about 17% of the company, and its partnership with Pfizer on a Covid-19 vaccine made BioNTech a global name in 2020.
How Uğur Şahin built his fortune
Şahin made his money through drug research, company building, and his ownership stake in BioNTech. He started in medicine and academic research, working in oncology and immunology before moving deeper into business. In 2001, he and immunologist Özlem Türeci cofounded Ganymed Pharmaceuticals. That company gave him an early business win when Astellas Pharma bought it in 2016 for $460 million. The same investors, Thomas and Andreas Struengmann, backed both Ganymed and BioNTech.
The bigger source of his wealth is BioNTech, the German biotech firm he cofounded in 2008 and still leads as CEO. BioNTech focuses on immunotherapies and mRNA-based medicines, including work in cancer and infectious disease. The company went public on the Nasdaq in October 2019, and Şahin owns about 17%. In early 2020, he led BioNTech to begin work on a coronavirus vaccine. BioNTech partnered with Pfizer in March 2020, and the vaccine won US approval in December.
How Forbes' estimate changed
Forbes has tracked large swings in Şahin's fortune as BioNTech's value moved over time. Forbes put his net worth at $4 billion in 2021, then $5.3 billion in 2022. It later estimated $5 billion in 2023 and $3.7 billion in 2024. Those changes fit the way his wealth is tied to biotech, especially his roughly 17% holding in BioNTech, a public company whose profile rose sharply after its vaccine partnership with Pfizer.
The estimate then moved back up and down again. Forbes valued his fortune at $4.3 billion in 2025 and $4.7 billion in 2026. As of October 20, 2026, Forbes' real-time billionaires tracker put him at $3.9 billion. He is listed as self-made, and the main driver is still the same: his stake in BioNTech, the company he cofounded in 2008 after already building one biotech business with Türeci.
Career and money timeline
- 2001
Şahin and Özlem Türeci cofounded Ganymed Pharmaceuticals.
- 2008
He cofounded BioNTech with backing from Thomas and Andreas Struengmann.
- 2016
Astellas Pharma acquired Ganymed Pharmaceuticals for $460 million.
- 2019
BioNTech went public on the Nasdaq in October 2019.
- 2020
He led BioNTech's coronavirus vaccine effort and partnered with Pfizer in March.
- 2026
Forbes valued his fortune at $4.7 billion on its 2026 billionaires list.
Uğur Şahin net worth FAQ
What is Uğur Şahin's net worth?
Uğur Şahin's net worth is an estimated $3.9 billion, according to Forbes Real-Time Billionaires, Uğur Şahin profile (October 20, 2026). It is an estimate, not an official figure.
How did Uğur Şahin get so rich?
The main sources named in the reporting we cite are: Biotechnology.
Is Uğur Şahin a billionaire?
Yes. Forbes Real-Time Billionaires estimates Uğur Şahin is worth $3.9 billion.
How has Uğur Şahin's net worth changed?
The earliest published estimate we track is $4 billion (2021, Forbes World's Billionaires List 2021). The latest is $3.9 billion (October 20, 2026).
What company is Uğur Şahin best known for?
He is best known as the cofounder and CEO of BioNTech. The company partnered with Pfizer on the first Covid-19 vaccine approved in the US.
Why is Uğur Şahin a billionaire?
His wealth is mainly tied to biotechnology and his about 17% stake in BioNTech. He also cofounded Ganymed Pharmaceuticals, which Astellas Pharma bought in 2016 for $460 million.
Sources
- Forbes Real-Time Billionaires, Uğur Şahin profile (October 20, 2026)
- Forbes World's Billionaires List 2021, Uğur Şahin profile (April 6, 2021)
- Forbes World's Billionaires List 2022, Uğur Şahin profile (April 5, 2022)
- Forbes World's Billionaires List 2023, Uğur Şahin profile (April 4, 2023)
- Forbes World's Billionaires List 2024, Uğur Şahin profile (April 2, 2024)
- Forbes World's Billionaires List 2025, Uğur Şahin profile (April 2025)
- Forbes World's Billionaires List 2026, Uğur Şahin profile (March 10, 2026)
- U.S. Bureau of Labor Statistics, Usual Weekly Earnings (Q2 2026) (July 2026)
- Federal Reserve, 2025 Survey of Consumer Finances (median family net worth, Table 4) (October 2026)
- Background facts: Wikipedia, Uğur Şahin (accessed October 22, 2026). Used for career facts only, never for figures.
Photo: BioNTech, CC BY-SA 4.0, via Wikimedia Commons.
Every number on this page is an estimate published by the source named next to it. We never fill in years with our own guesses. How we handle estimates.